Virpax Pharmaceuticals Statistics
Total Valuation
VRPX has a market cap or net worth of $8.18 million. The enterprise value is $6.32 million.
| Market Cap | 8.18M |
| Enterprise Value | 6.32M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRPX has 4.81 million shares outstanding.
| Shares Outstanding | 4.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 6.26% |
| Owned by Institutions (%) | 0.03% |
| Float | 1.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.72
| Current Ratio | 0.72 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -345.90%.
| Return on Equity (ROE) | -345.90% |
| Return on Assets (ROA) | -161.80% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.41M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.91% in the last 52 weeks. The beta is 1.16, so VRPX's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -81.91% |
| 50-Day Moving Average | 1.00 |
| 200-Day Moving Average | 3.61 |
| Relative Strength Index (RSI) | 63.30 |
| Average Volume (20 Days) | 17,801,680 |
Short Selling Information
The latest short interest is 36,629, so 0.76% of the outstanding shares have been sold short.
| Short Interest | 36,629 |
| Short Previous Month | 28,490 |
| Short % of Shares Out | 0.76% |
| Short % of Float | 3.51% |
| Short Ratio (days to cover) | 0.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.34M |
| Pretax Income | -16.89M |
| Net Income | -16.89M |
| EBITDA | -16.89M |
| EBIT | -16.89M |
| Earnings Per Share (EPS) | -$14.42 |
Balance Sheet
The company has $1.87 million in cash and no debt, giving a net cash position of $1.87 million or $0.39 per share.
| Cash & Cash Equivalents | 1.87M |
| Total Debt | n/a |
| Net Cash | 1.87M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | -1.21M |
| Book Value Per Share | -0.25 |
| Working Capital | -1.21M |
Cash Flow
| Operating Cash Flow | -15.57M |
| Capital Expenditures | n/a |
| Free Cash Flow | -15.57M |
| FCF Per Share | -$13.30 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRPX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -206.41% |
| FCF Yield | -190.34% |
Analyst Forecast
The average price target for VRPX is $3.00, which is 76.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 76.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Mar 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |